The Business of Science | GenomeWeb

The UK's University College London Business is a unique technology-transfer company that manages the institution's research portfolio, The Chronicle of Higher Education reports. While some of the hundreds of projects the firm manages are profitable for the university, others may take many years before they make money. Some may never make a profit for the school at all.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.